Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs MedLeanRx
CoreAge Rx and MedLeanRx both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxMedLeanRx
Ranked #212 · Grade C
Best for: A Texas family that wants a compounded option and a brand-name route from the same practice.
Visit MedLeanRxThe verdict
CoreAge Rx edges out MedLeanRx on the Rx-Readiness Score, 95 to 52 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
MedLeanRx is still a genuine option — texas only, and it prints the disclosure most of this batch omitted: "$99/mo + medication cost" on the Wegovy tier, stating on the card that the fee buys the service and the drug is billed on top. Compounded semaglutide is $149 as a weekly vial or a daily tablet, with brand-name Wegovy and Zepbound available — their medication costs unpublished. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | MedLeanRx |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 52/100 · C |
| Overall rank | #1 | #212 |
| Semaglutide | $99/mo | $149/mo for the compounded vial or tablets |
| Tirzepatide | $149/mo | Brand-name Zepbound offered; price not published |
| Coverage | All 50 states | Texas only |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
MedLeanRx
Ranked #212 · Grade C
What we like
- Says plainly that the Wegovy tier is "$99/mo + medication cost" rather than implying the fee covers the drug
- Offers FDA-approved Wegovy and Zepbound alongside the compounded options
- A needle-free daily oral semaglutide at the same $149 as the weekly injection
The caveats
- Texas only — the narrowest coverage on this page
- The brand-name medication costs are not published, so the total for Wegovy or Zepbound is unknown up front
- Tirzepatide appears only as brand-name Zepbound; no compounded tirzepatide price is given
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and MedLeanRx against other providers on our shortlist.
Or browse the full comparison hub.